Advancing the world of health™

BD maintains a SOC2+ program for multiple BD products that collect and process patient health information in accordance with the HIPAA security rule. These annual audits address the Trust Principles for Security and, for our cloud-based products, Availability. These reports are prepared by an independent third party and provide assurance regarding the operational effectiveness of BD internal controls and the security of BD products.

UL CAP, which stands for Underwriters Laboratories Cybersecurity Assurance Program, is an independently audited certification that demonstrates the cybersecurity of medical device products through a rigorous program of analysis. UL CAP cybersecurity testing is extensive and challenges BD products against known cybersecurity vulnerabilities, malware, malformed input (fuzz testing), structured penetration, static source code analysis, static binary and bytecode analysis, and verification of security controls (access control, user authentication and authorization, remote communication, cryptography and software updates).

BD maintains Product Security White Papers for its software-enabled products. The purpose of these documents is to provide details on how BD security and privacy practices have been applied and what our customers should know about maintaining security throughout the entire product life cycle. Each white paper includes a Manufacturer Disclosure Statement for Medical Device Security (MDS2 attestation).